Abstract
POSTER: ALL-389 Venetoclax in the Treatment of Relapsed Refractory Early T Cell Precursor ALL (ETP-ALL). Case Report and Review of The Literature
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have